a nonsignificant trendP=0.09
A nonsignificant trend favored allergy symptom reduction in the nonadenoid hypertrophy group (69.23% vs. 50.94%; P=0.09), whereas there was no intergroup difference in medication use reduction (P=0.50).
A nonsignificant trend favored allergy symptom reduction in the nonadenoid hypertrophy group (69.23% vs. 50.94%; P=0.09), whereas there was no intergroup difference in medication use reduction (P=0.50).
While there was a trend toward a reduction in allergy symptoms in the nonadenoid hypertrophy group, the difference did not reach statistical significance.